Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has issued an update.
Aarti Drugs Limited has announced the opening of a special window for the re-lodgement of transfer requests of physical shares, as per the SEBI circular dated July 2, 2025. This move is significant for shareholders holding physical shares, as it aligns with regulatory requirements and facilitates smoother transactions, potentially enhancing shareholder value and compliance with market regulations.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the manufacturing of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company serves a variety of markets, including domestic and international sectors, with a strong emphasis on quality and innovation in its product offerings.
Average Trading Volume: 33,496
Technical Sentiment Signal: Buy
Current Market Cap: 44.33B INR
See more insights into AARTIDRUGS stock on TipRanks’ Stock Analysis page.